Literature DB >> 12371852

Observation of topical catalysis by sphingomyelinase coupled to microspheres.

Tuula A Nurminen1, Juha M Holopainen, Hongxia Zhao, Paavo K J Kinnunen.   

Abstract

Sphingomyelinase, SMase (EC 3.1.4.12), was coupled onto amino-derivatized acrylate microspheres and was shown to retain its catalytic activity. The immobilized enzyme allows one to carry out topical enzymatic reaction in a controlled manner. Accordingly, these spheres were held with a micropipet and using micromanipulator brought into contact with a giant liposome membrane composed of phosphatidylcholine and sphingomyelin (SOPC/C16:0-SM, 0.75:0.25, molar ratio), representing the substrate for the immobilized enzyme. The macroscopic consequences of the enzyme reaction were visualized using fluorescence microscopy as well as differential interference contrast microscopy. The surface contact of the giant vesicle and immobilized enzyme causes membrane microdomain formation and domain clustering (capping) in the membrane and subsequent shedding of small vesicles from the membrane into the interior of the giant liposome. The method described represents a novel approach to study enzymatic reactions and allows manipulating giant vesicles as well as cultured cells in a spatially controlled manner.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12371852     DOI: 10.1021/ja017807r

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  27 in total

Review 1.  Ion channels and membrane rafts in apoptosis.

Authors:  I Szabò; C Adams; E Gulbins
Journal:  Pflugers Arch       Date:  2004-04-08       Impact factor: 3.657

Review 2.  Ceramide-rich platforms in transmembrane signaling.

Authors:  Branka Stancevic; Richard Kolesnick
Journal:  FEBS Lett       Date:  2010-02-20       Impact factor: 4.124

Review 3.  Role of sphingolipids in the biogenesis and biological activity of extracellular vesicles.

Authors:  Claudia Verderio; Martina Gabrielli; Paola Giussani
Journal:  J Lipid Res       Date:  2018-05-31       Impact factor: 5.922

4.  Neisseria meningitidis Type IV Pili Trigger Ca2+-Dependent Lysosomal Trafficking of the Acid Sphingomyelinase To Enhance Surface Ceramide Levels.

Authors:  Simon Peters; Jan Schlegel; Jérôme Becam; Elita Avota; Markus Sauer; Alexandra Schubert-Unkmeir
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

5.  Exogenous sphingomyelinase causes impaired intestinal epithelial barrier function.

Authors:  Jurgen Bock; Gerhard Liebisch; Joachim Schweimer; Gerd Schmitz; Gerhard Rogler
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

Review 6.  Exosomal miRNAs: novel players in viral infection.

Authors:  Javid Sadri Nahand; Maryam Mahjoubin-Tehran; Mohsen Moghoofei; Mohammad Hossein Pourhanifeh; Hamid Reza Mirzaei; Zatollah Asemi; Alireza Khatami; Farah Bokharaei-Salim; Hamed Mirzaei; Michael R Hamblin
Journal:  Epigenomics       Date:  2020-02-25       Impact factor: 4.778

7.  The role of sphingolipids and ceramide in pulmonary inflammation in cystic fibrosis.

Authors:  Katrin Anne Becker; Joachim Riethmüller; Yang Zhang; Erich Gulbins
Journal:  Open Respir Med J       Date:  2010-03-30

8.  Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid.

Authors:  Madalina Opreanu; Todd A Lydic; Gavin E Reid; Kelly M McSorley; Walter J Esselman; Julia V Busik
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-13       Impact factor: 4.799

9.  Diacylglycerol-rich domain formation in giant stearoyl-oleoyl phosphatidylcholine vesicles driven by phospholipase C activity.

Authors:  Karin A Riske; Hans-Günther Döbereiner
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

10.  Induction of membrane ceramides: a novel strategy to interfere with T lymphocyte cytoskeletal reorganisation in viral immunosuppression.

Authors:  Evelyn Gassert; Elita Avota; Harry Harms; Georg Krohne; Erich Gulbins; Sibylle Schneider-Schaulies
Journal:  PLoS Pathog       Date:  2009-10-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.